|
|
Topically applied Taclonex® (calcipotriene and betamethasone dipropionate) Ointment can be absorbed in sufficient amounts to produce systemic effects. (See PRECAUTIONS).
Taclonex® (calcipotriene and betamethasone dipropionate) Ointment is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
Taclonex® (calcipotriene and betamethasone dipropionate) Ointment is contraindicated in patients with known or suspected disorders of calcium metabolism.
Taclonex® (calcipotriene and betamethasone dipropionate) Ointment is contraindicated in patients with erythrodermic, exfoliative and pustular psoriasis.
Last reviewed on RxList: 10/17/2007
This monograph has been modified to include the generic and brand name in many instances.
Here is a collection of user reviews for the medication Taclonex sorted by most helpful.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.
Copyright © 2012 by WebMD, LLC.
RxList does not provide medical advice, diagnosis or treatment. See additional information.
Updated & New